Legend Biotech LEGN Cash Flow Statement (2019-2026)

NASDAQ LEGN
$21.52 -0.23 (-1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Legend Biotech Quarterly Cash Flow Statement

Periods 29 quarters
Latest Jun 2026

Legend Biotech reported cash from operations of -$20.90M and free cash flow of -$13.40M for the quarter ended Jun 2026, down 58.3% year over year. This cash flow statement covers 29 quarters of results from Jun 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-124.75M-410.81M-31.96M-192.91M-84.65M-135.57M-111.84M-198.55M-62.78M-144.82M-59.78M-17.74M-116.45M26.40M-97.40M-124.20M-38.46M-30.90M-51.90M77.80M
Share-based CompensationStock Comp.
6.92M5.20M5.67M9.45M10.24M8.97M7.07M15.64M12.38M12.59M18.70M21.74M15.11M13.40M15.90M18.70M15.06M14.90M19.30M17.40M
Cash from Discontinued OperationsCash from Discont. Ops
-95.64M-82.08M
Gains from Sales and DivestituresGains Divest
0.02M-0.00M-0.01M0.47M0.07M0.07M0.08M0.00M0.00M0.05M0.20M
Gains from Investment SecuritiesGains Investment
1.13M3.47M-34.90M65.90M-61.20M-20.90M-20.00M105.75M0.05M1.11M-1.11M-165.40M
Asset Writedowns and ImpairmentWritedown
0.35M0.23M0.77M-1.34M6.83M-2.43M-3.80M-1.10M0.90M4.00M-6.10M1.60M
Non-cash ItemsNon-Cash Items
-77.34M-64.41M
Cash from OperationsCash from Ops.
-44.59M-198.47M-78.69M-0.74M-72.11M-49.74M-139.22M-97.57M-60.85M-95.64M15.52M-1.65M-75.82M-82.10M-103.60M-13.20M28.80M-12.20M-85.10M-20.90M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.24M0.42M0.26M0.54M0.82M0.85M0.83M0.12M0.50M6.36M0.89M0.37M5.79M3.66M2.80M3.50M3.92M9.28M13.20M7.70M
Amortization of Deferred ChargesAmort. Deferred Charges
0.21M0.60M0.99M1.69M3.25M4.86M5.11M5.18M5.68M5.83M5.47M5.48M5.50M5.14M5.10M5.20M5.62M5.48M5.50M5.80M
Depreciation & Amortization (CF)Dep. & Amort.
2.77M-0.02M3.18M1.57M2.94M2.48M3.12M2.18M2.67M5.35M2.80M2.78M2.38M6.80M2.30M2.30M2.11M12.00M2.40M4.00M
Change in Working Capital
Change in ReceivablesChange Receivables
13.50M-48.91M-0.04M49.99M0.40M-0.03M0.03M-15.01M15.04M-99.07M96.73M-9.76M12.36M-5.54M5.90M-26.20M25.81M-11.21M11.40M1.60M
Change in InventoryChange Inventory
0.07M-0.12M-1.15M-5.26M-2.27M-8.61M-2.17M-3.25M-3.58M-3.70M-4.47M-1.39M-5.08M-6.26M-3.20M-2.80M5.35M-3.85M0.70M-6.00M
Change in Account PayablesChange Payables
0.59M-4.55M2.67M2.50M25.33M41.94M-3.08M-8.27M-4.37M-34.48M22.80M-1.95M-12.82M6.08M19.50M16.50M24.30M-15.90M-8.10M2.90M
Change in Accured ExpensesChange Accured Exp.
36.15M-63.80M-21.88M75.88M63.54M165.88M-39.18M18.92M-8.52M26.08M7.38M38.75M1.03M-3.26M-39.10M20.20M7.89M47.11M-65.20M-9.60M
Change in TaxesChange Taxes
0.56M3.71M-0.70M0.07M-0.92M-0.05M-0.70M-11.90M-3.30M-2.02M-1.18M-0.20M-9.30M
Other Working Capital ChangesOther WC Changes
-15.73M14.74M9.21M0.60M-12.18M-8.29M19.85M-4.18M0.50M1.30M-3.45M5.05M-2.00M4.30M
Investing Activities
Capital ExpendituresCapex
-11.48M-42.20M-12.12M0.32M-2.58M-20.93M-4.27M-6.09M-5.38M-4.36M-6.24M-3.42M-2.06M-2.37M-2.00M-9.20M-5.03M-12.37M-7.50M-7.50M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.01M-0.02M0.05M-0.05M-0.00M
Change in Acquisitions & DivestmentsChange Acquisitions
43.07M168.22M288.23M119.57M-87.16M54.02M49.71M336.05M2,336.99M34.70M498.27M688.04M358.35M840.30M563.70M3,710.30M381.06M46.70M188.20M-785.20M
Cash from Investing ActivitiesCash from Investing
-105.67M-194.98M-232.50M2.58M127.89M24.93M16.03M-121.68M-209.07M407.51M-396.15M-695.63M329.08M-87.90M256.60M-165.50M-19.99M638.50M-168.00M-120.00M
Financing Activities
Other financing activitiesOther financing
-1.06M0.46M1.06M0.79M-0.01M-0.00M0.00M11.80M1.59M-1.66M9.18M0.59M1.40M0.30M1.29M0.31M0.10M0.20M
Cash from Financing ActivitiesCash from Financing
1.14M323.56M0.03M1.01M377.73M-0.78M-0.44M790.05M0.96M0.93M0.83M0.95M4.25M-0.30M0.60M-0.90M0.65M-0.60M-1.20M167.70M
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued
377.64M114.87M0.02M
Additional items
Exchange Rate EffectFX Effect
-0.76M0.08M0.01M-0.86M-0.55M-1.11M-2.35M2.37M-0.78M1.45M-0.34M0.01M0.52M-2.30M1.40M4.40M2.88M-2.70M-1.20M-0.30M
Change in Cash
-149.12M350.53M-311.16M2.85M433.50M-25.59M-123.63M1,356.84M-1055.00M312.79M-379.80M-696.33M257.69M-172.60M155.00M-175.20M12.34M623.06M-255.50M26.50M
Beginning Cash Balance
455.69M688.94M
Free Cash FlowFCF
-33.11M-156.27M-66.57M-1.06M-69.53M-28.82M-134.94M-91.48M-55.47M-91.28M21.76M1.77M-73.76M-79.73M-101.60M-4.00M33.84M0.17M-77.60M-13.40M
Net Cash FlowNCF
-149.12M-69.89M-311.16M2.85M433.50M-25.59M-123.63M570.80M-268.96M312.79M-379.80M-696.33M257.50M-170.30M153.60M-179.60M9.47M625.70M-254.30M26.80M